cp wire

CP Wire Articles

  • The neural stem cell line into APP/PS1 mice that carry genes bearing mutations associated with onset of AD in humans
  • NSI-532.IGF1 is a second-generation cell therapy candidate that... read more
Thu, 10/25/18 - 09:48 am
admin
  • The FDA previously granted ruxolitinib Breakthrough Therapy Designation for the treatment of acute GVHD
  • Jakafi is marketed by Incyte in the United States and by Novartis as Jakavi (... read more
Thu, 10/25/18 - 09:33 am
admin
  • Xofluxa is a single-dose one-time treatment compared to Tamiflu's twice daily for five day regimen
  • In two trials, patients taking Xofluxa had a shorter duration of flu symptoms... read more
Wed, 10/24/18 - 12:39 pm
admin
The 18th Annual Temperature Controlled Logistics Conference will bring together supply chain, logistics and quality experts from around the globe to experience four days of ‘unmissable’... read more
Wed, 10/24/18 - 12:30 pm
admin
  • Zanubrutinib demonstrated a high overall response rate of 80 percent
  • Zanubrutinib was recently granted Fast Track Designation by the US FDA for Waldenström macroglobulinemia (WM)... read more
Wed, 10/24/18 - 11:53 am
admin
  • 60.3% of all randomised ustekinumab-treated patients who entered the long-term extension study were in clinical remission at week 152
  • Of those patients who were naïve to TNF... read more
Wed, 10/24/18 - 09:45 am
admin



TP Therapeutics announced on 10/24/18 a global collaboration agreement to develop and commercialize a next-generation sequencing (NGS) companion diagnostic (CDx) for repotrectinib, TP... read more

Wed, 10/24/18 - 09:30 am
admin
  • Bain Capital committed $350 million to the company
  • Pfizer is contributing a portfolio of assets that includes three clinical-stage compounds


Bain Capital, LP and... read more

Tue, 10/23/18 - 10:14 am
admin
  • OMS721 also has orphan status for two other conditions
  • OMS721 is Omeros’ lead human MASP-2 antibody
  • The drug was awarded fast track designation for the treatment of patients... read more
Tue, 10/23/18 - 09:43 am
admin
  • Glucagon is the standard of care for treating severe hypoglycemia
  • Mild to moderate hypoglycemia occurs monthly and severe hypoglycemia can occur several times per year
  • The... read more
Tue, 10/23/18 - 09:24 am
admin

Seres Therapeutics, Inc. (Nasdaq:MCRB) announced on 10/22/18 the appointment of Kevin Horgan, M.D., as Executive Vice President and Chief Medical Officer. Dr. Horgan will lead Seres’ clinical... read more

Mon, 10/22/18 - 05:29 pm
admin
  • Pamiparib is currently in Phase 3 trials globally and in China as a monotherapy
  • Of 23 patients with solid tumors, Ten had a best response of stable disease; four patients had a best... read more
Mon, 10/22/18 - 10:01 am
admin
  • In the Tumor Treating Fields plus gemcitabine cohort, progression free survival and overall survival were each more than double those of the gemcitabine-treated historical control
  • ... read more
Mon, 10/22/18 - 09:47 am
admin
  • The Index is a measurement meant to assess the extent of microbiome restoration following microbiota based therapy
  • Rebiotix is developing two microbiota based formulations to treat... read more
Mon, 10/22/18 - 09:31 am
admin


TP Therapeutics announced on 10/19/18 its completion of an $80 million round of mezzanine financing. Foresite Capital and venBio Partners led the investment syndicate, with participation from... read more

Fri, 10/19/18 - 09:29 am
admin

Vertex Pharmaceuticals (Europe) announced on 10/19/18 that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO®(... read more

Fri, 10/19/18 - 09:13 am
admin

Takeda Pharmaceutical Company Limited (TSE: 4502) announced on 8/19/18 that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed... read more

Fri, 10/19/18 - 09:05 am
admin

Symberix announced on 10/18/18  has been awarded three Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH), entered into a Research Collaboration... read more

Thu, 10/18/18 - 12:33 am
admin

LNC Therapeutics announced on 10/15/18 that it has signed an exclusive license agreement with Cornell University (Ithaca, NY, USA) for its Christensenella patent family.

Christensenella is... read more

Wed, 10/17/18 - 11:38 pm
admin

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.